| Objective To explore the role of the balance of Treg/Th17cells inpathogenesis of aplastic anemia (AA), and to investigate the regulatoryeffect of umbilical cord-derived mesenchymal stem cells(UC-MSCs) onthe ratio of Treg/Th17cells in patients with AA.Methods1ã€UC-MSCs were isolated, cultured and identified in vitro.2ã€Flow Cytometry(FCM)was used to detect the percentage of Tregcells and Th17cells among peripheral blood mononuclear cells(PBMCs)from10healthy controls and15AA patients respectively by FCM, and theratio of Treg/Th17was compared.3ã€PBMCs of the patients with AA was cultured solely and co-culturedwith UC-MSCs for72hours, the percentage of Treg cells and Th17cells inPBMC and the ratio of Treg/Th17were compared respectively between thetwo groups.Results1ã€Surface antigens of MSCs, CD90ã€CD105with positive rate≥98% and CD34ã€CD45positive rate≤1%were detected by the FCM.2ã€The percentage of Treg cells in AA patients group peripheral bloodwas significantly lower than that in healthy control group(P <0.05), whilethe percentage of Th17cells was higher and the ratio of Treg/Th17cellswas lower.3ã€Since PBMCs of AA patients was co-cultured with UC-MSCs, thepercentage of Treg cells in AA patients group peripheral blood wassignificantly higher than that in the sole-culture group(P <0.05), while thepercentage of Th17cells was lower, and the ratio of Treg/Th17cells washigher than that in the sole-culture group.Conclusion1ã€The differential imbalance between Treg cells and Th17cells occursin the peripheral blood of AA patients.2ã€UC-MSCs may regulate the imbalance between Treg cells and Th17cells by inducing the production and aggregation of Treg, and inhibiting thedifferentiation of Th17. |